PARSABIV (Amgen Inc)
Welcome to the PulseAid listing for the PARSABIV drug offered from Amgen Inc. This Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Amgen Inc |
NON-PROPRIETARY NAME: | etelcalcetide |
SUBSTANCE NAME: | ETELCALCETIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-04-03 |
END MARKETING DATE: | 0000-00-00 |
PARSABIV HUMAN PRESCRIPTION DRUG Details:
Item Description | PARSABIV from Amgen Inc |
LABELER NAME: | Amgen Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/.5mL) |
START MARKETING DATE: | 2017-04-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55513-740_4100ce15-06c6-425b-955c-de568d81371f |
PRODUCT NDC: | 55513-740 |
APPLICATION NUMBER: | NDA208325 |
Other ETELCALCETIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: